PL2231636T3 - Pochodne pirazolowe i ich zastosowanie jako inhibitorów kinaz zależnych od cyklin - Google Patents

Pochodne pirazolowe i ich zastosowanie jako inhibitorów kinaz zależnych od cyklin

Info

Publication number
PL2231636T3
PL2231636T3 PL08857078T PL08857078T PL2231636T3 PL 2231636 T3 PL2231636 T3 PL 2231636T3 PL 08857078 T PL08857078 T PL 08857078T PL 08857078 T PL08857078 T PL 08857078T PL 2231636 T3 PL2231636 T3 PL 2231636T3
Authority
PL
Poland
Prior art keywords
inhibitors
pyrazole derivatives
cyclin dependent
dependent kinases
useful
Prior art date
Application number
PL08857078T
Other languages
English (en)
Inventor
Christopher Thomas Brain
Young Shin Cho
Ying Hou
Moo Sung
Original Assignee
Novartis Ag
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Astex Therapeutics Ltd filed Critical Novartis Ag
Publication of PL2231636T3 publication Critical patent/PL2231636T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL08857078T 2007-12-07 2008-12-08 Pochodne pirazolowe i ich zastosowanie jako inhibitorów kinaz zależnych od cyklin PL2231636T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1227607P 2007-12-07 2007-12-07
PCT/EP2008/067037 WO2009071701A1 (en) 2007-12-07 2008-12-08 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
EP08857078A EP2231636B1 (en) 2007-12-07 2008-12-08 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases

Publications (1)

Publication Number Publication Date
PL2231636T3 true PL2231636T3 (pl) 2012-04-30

Family

ID=40343520

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08857078T PL2231636T3 (pl) 2007-12-07 2008-12-08 Pochodne pirazolowe i ich zastosowanie jako inhibitorów kinaz zależnych od cyklin

Country Status (15)

Country Link
US (1) US8367687B2 (pl)
EP (1) EP2231636B1 (pl)
JP (1) JP2011506303A (pl)
KR (1) KR20100098521A (pl)
CN (1) CN101883764B (pl)
AT (1) ATE524459T1 (pl)
AU (1) AU2008333136B2 (pl)
BR (1) BRPI0821151A2 (pl)
CA (1) CA2707989A1 (pl)
EA (1) EA018459B1 (pl)
ES (1) ES2374480T3 (pl)
MX (1) MX2010006203A (pl)
PL (1) PL2231636T3 (pl)
PT (1) PT2231636E (pl)
WO (1) WO2009071701A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR069165A1 (es) 2007-11-05 2010-01-06 Novartis Ag Derivados de 4-bencilamino-1-carboxacilpiperidina como inhibidores de cetp utiles para el tratamiento de hiperlipidemia
PT2404901E (pt) 2007-12-03 2013-08-29 Novartis Ag Derivados de 4-benzilamino-pirrolidina 1,2-dissubstituídos como inibidores de cetp úteis para o tratamento de doenças tais como a hiperlipidemia ou a arteriosclerose
EP2432767B1 (en) * 2009-05-19 2013-06-26 Dow AgroSciences LLC Compounds and methods for controlling fungi
KR101830455B1 (ko) * 2010-04-13 2018-02-20 노파르티스 아게 시클린 의존성 키나제 ４ 또는 시클린 의존성 키나제 （ｃｄｋ４／６） 억제제 및 ｍｔｏｒ 억제제를 포함하는 암 치료를 위한 조합물
US8354420B2 (en) 2010-06-04 2013-01-15 Genentech, Inc. Aminopyrimidine derivatives as LRRK2 inhibitors
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
SI2638031T1 (en) 2010-11-10 2018-02-28 Genentech, Inc. Pyrazole aminopyrimidine derivatives as LRRK2 modulators
CN103547580B (zh) 2011-03-22 2016-12-07 阿迪维纳斯疗法有限公司 取代的稠合三环化合物、其组合物及医药用途
AU2012322660B2 (en) 2011-10-11 2017-07-06 Dana Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
IN2015DN02008A (pl) 2012-09-21 2015-08-14 Advinus Therapeutics Ltd
JP6412503B2 (ja) 2012-11-21 2018-10-24 ピーティーシー セラピューティクス， インコーポレイテッド 置換逆ピリミジンＢｍｉ−１阻害剤
KR102232595B1 (ko) * 2013-08-30 2021-03-26 피티씨 테라퓨틱스, 인크. 치환된 피리미딘 bmi-1 저해제
EP3071553A4 (en) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
JP6927882B2 (ja) 2015-04-02 2021-09-01 プロキシマジェン，リミティド ライアビリティ カンパニー 癌の新治療法
CN108137562B (zh) 2015-08-04 2021-11-30 耶路撒冷希伯来大学伊森姆研究发展有限公司 吡唑嘧啶衍生物及其用途
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
JP2021535198A (ja) 2018-08-17 2021-12-16 ピーティーシー セラピューティクス， インコーポレイテッド 膵臓癌を治療する方法
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
TW202100520A (zh) * 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
CN116348458A (zh) 2019-08-14 2023-06-27 因赛特公司 作为cdk2抑制剂的咪唑基嘧啶基胺化合物
CN119930611A (zh) 2019-10-11 2025-05-06 因赛特公司 作为cdk2抑制剂的双环胺
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
EP4725942A1 (en) 2024-10-09 2026-04-15 Sibylla Biotech S.p.A. Compounds active on cyclin d1 pathway and their use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979686B1 (en) * 2001-12-07 2005-12-27 Pharmacia Corporation Substituted pyrazoles as p38 kinase inhibitors
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
US20020111353A1 (en) 2000-12-05 2002-08-15 Mark Ledeboer Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
AU2002308748A1 (en) * 2001-05-16 2002-11-25 Vertex Pharmaceuticals Incorporated Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
US7279473B2 (en) * 2001-12-17 2007-10-09 Smithkline Beecham Corporation Pyrazolopyridazine derivatives
GB0215844D0 (en) 2002-07-09 2002-08-14 Novartis Ag Organic compounds
AU2003301302A1 (en) 2002-10-15 2004-05-04 Smithkline Beecham Corporation Pyradazine compounds as gsk-3 inhibitors
GB0409080D0 (en) * 2004-04-23 2004-05-26 Biofocus Discovery Ltd Compounds which interact with protein kinases
EP1917258A2 (en) 2005-08-26 2008-05-07 SmithKline Beecham Corporation Pyrimidinyl-pyrazole inhibitors of aurora kinases
CN103121996B (zh) * 2006-04-19 2015-10-21 默克雪兰诺有限公司 用作mek抑制剂的杂芳基取代的芳基氨基吡啶衍生物
WO2007132220A1 (en) 2006-05-12 2007-11-22 Cyclacel Limited Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
US20100144756A1 (en) * 2007-07-13 2010-06-10 Bolea Christelle Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

Also Published As

Publication number Publication date
EP2231636B1 (en) 2011-09-14
EA201000879A1 (ru) 2010-12-30
JP2011506303A (ja) 2011-03-03
US20100280033A1 (en) 2010-11-04
CN101883764B (zh) 2013-11-13
EA018459B1 (ru) 2013-08-30
ES2374480T3 (es) 2012-02-17
KR20100098521A (ko) 2010-09-07
AU2008333136A1 (en) 2009-06-11
ATE524459T1 (de) 2011-09-15
CN101883764A (zh) 2010-11-10
CA2707989A1 (en) 2009-06-11
BRPI0821151A2 (pt) 2015-06-16
PT2231636E (pt) 2012-01-02
AU2008333136B2 (en) 2012-05-10
US8367687B2 (en) 2013-02-05
MX2010006203A (es) 2010-06-25
EP2231636A1 (en) 2010-09-29
WO2009071701A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
MX2010006203A (es) Derivados de pirazol y uso de los mismos como inhibidores de cinasas dependientes de ciclina.
TNSN08481A1 (en) Pyrrolopyrimidine compounds and their uses
MX2009006535A (es) Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina.
TW200801008A (en) Protein kinase inhibitors
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2009013729A (es) Imidazopirazinas como inhibidores de proteina quinasa.
WO2010068483A3 (en) Mlk inhibitors and methods of use
MX2009011810A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
BRPI0807717A2 (pt) Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
TNSN08400A1 (en) Organic compounds and their uses
MX2009012719A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
WO2010005876A3 (en) Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
WO2007087068A3 (en) Inhibitors of tyrosine kinases and uses thereof
WO2009064486A3 (en) Inhibitors of pim protein kinases, compositions, and methods for treating cancer
MX367398B (es) Inhibidores de la actividad de serina/treonina quinasa.
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
NZ590550A (en) Inhibitors of Apoptosis (IAP) for treating cancer
MX2009005300A (es) Combinacion de un inhibidor de acido desoxirribonucleico polimerasa-alfa y un inhibidor de una cinasa de punto de verificacion para trastornos proliferativos.
IL197080A0 (en) Pyrimidone compounds as gsk-3 inhibitors
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
TNSN08496A1 (en) Aminothiazoles and their uses
WO2010062848A8 (en) Substituted pyrazole compounds
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment